The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Azure Healthcare’s (AZV) subsidiary, Austco Canada, has been awarded a $1.6 million contract to supply its Tacera Nurse Call platform to a new 350 bed hospital
  • The contract was from building and construction company EllisDon who are building the hospital
  • Austco’s technology will be integrated with EllisDon’s technology which will enhance communication between patients and caregivers
  • The new hospital is expected to be completed in 2023
  • On market close for the day, Azure is down 3.23 per cent and is trading for 9 cents per share.

Azure Healthcare’s (AZV) subsidiary, Austco Canada, has received $1.6 million contract to supply its Tacera Nurse Call platform to a new 350 bed hospital.

The technology enables nurse call alarms to be monitored with alarm and response data then collected to measure the performance outcomes.

Austco Canada was picked by construction and building services company EllisDon as its software is the most flexible and advanced.

The new hospital is currently construction and is expected to be completed in 2023, with the Austco Tacera system expected to be delivered in 2022.

All beds will feature the Austco Patient System which will be integrated with EllisDon’s Building Management System. Both systems will enhance communication between patients and caregivers.

“We are committed to providing innovative solutions that deliver quality care and optimise the patient experience,” Austco CEO Clayton Astles said.

“Our exceptional Tacera nurse call system is integral to quality operation of any hospital and our technology drives productivity and ensures improvement in patient care,” he added.

On market close for the day, Azure is down 3.23 per cent and is trading for 9 cents per share.

AZV by the numbers
More From The Market Online

Pacific Edge revenues up, cash costs down on reorganisation

Pacific Edge Ltd has balanced a drop in cash costs with falls in total cash at…

Telix Pharma gears up to launch US IPO

Telix Pharmaceuticals has announced it's working with Morgan Stanley to list depository shares on the NASDAQ.

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…